miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin

Oncotarget

Volumn 6, Issue 28, 2015, Pages 25962-25974

  Chen, Wen Shu ^a,b,c   Yen, Chia Jui ^d   Chen, Yun Ju ^e,f   Chen, Jhen Yu ^b,c   Wang, Li Yun ^b,c   Chiu, Shu Jun ^g,h   Shih, Wen Ling ⁱ   Ho, Chien Yi ^b   Wei, Tzu Tang ^a   Pan, Hsiao Lin ^e   Chien, Pei Hsuan ^e   Hung, Mien Chie ^b,c,j   Chen, Ching Chow ^a   Huang, Wei Chien ^b,c,k  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e E DA HOSPITAL   (Taiwan)

^f I SHOU UNIVERSITY   (Taiwan)

^g TZU CHI UNIVERSITY   (Taiwan)

^h TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

ⁱ NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k ASIA UNIVERSITY   (Taiwan)

more..

Author keywords

HBx; Hepatocellular carcinoma cell; Maspin; Metastasis; MicroRNA

Indexed keywords

MASPIN; MESSENGER RNA; MICRORNA; MICRORNA 103; MICRORNA 107; MICRORNA 21; MICRORNA 7; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTINEOPLASTIC AGENT; HEPATITIS B VIRUS X PROTEIN; MIRN107 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN7 MICRORNA, HUMAN; SERINE PROTEINASE INHIBITOR; SERPIN-B5; TRANSACTIVATOR PROTEIN;

ANOIKIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG RESISTANCE; EMBRYO; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MASPIN GENE; OVERALL SURVIVAL; PROTEIN EXPRESSION; 3' UNTRANSLATED REGION; CELL SURVIVAL; DISEASE COURSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEP-G2 CELL LINE; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; LIVER TUMOR; MALE; METABOLISM; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANOIKIS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MULTIVARIATE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; TRANS-ACTIVATORS;

EID: 84944463053     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4504     Document Type: Article

References (41)

1. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, Martinez AC, Arroyo AG, Lopez-Cabrera M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest. 2002; 110:1831-1838.
2. Lee JO, Lee KW, Oh DY, Kim JH, Im SA, Kim TY, Bang YJ. Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. Ann Oncol. 2009; 20:1402-1407.
3. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res. 2008; 659:176-184.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. International Journal of Cancer. 2001; 94:153-156.
5. Bartosch B. Hepatitis B and C viruses and hepatocellular carcinoma. Viruses. 2010; 2:1504-1509.
6. Fink SA, Jacobson IM. Managing patients with hepatitisBrelated or hepatitisC-related decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2011; 8:285-295.
7. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004; 127:S56-61.
8. Diao J, Garces R, Richardson CD. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev. 2001; 12:189-205.
9. Hodgson AJ, Keasler VV, Slagle BL. Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res. 2008; 68:10341-10348.
10. Wang WH, Hullinger RL, Andrisani OM. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem. 2008; 283:25455-25467.
11. Cheng P, Li Y, Yang L, Wen Y, Shi W, Mao Y, Chen P, Lv H, Tang Q, Wei Y. Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase. Oncol Rep. 2009; 22:1101-1107.
12. Bartosch B, Thimme R, Blum HE, Zoulim F. Hepatitis C virus-induced hepatocarcinogenesis. J Hepatol. 2009; 51:810-820.
13. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005; 19:3-23.
14. Lee CF, Ling ZQ, Zhao T, Lee KR. Distinct expression patterns in hepatitis B virus-and hepatitis C virus-infected hepatocellular carcinoma. World J Gastroenterol. 2008; 14:6072-6077.
15. Ng J, Wu J. Hepatitis B-and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences. Hepat Mon. 2012; 12:e7635.
16. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994; 263:526-529.
17. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol. 2006; 209:617-624.
18. Blandamura S, Giacomelli L, Leo G, Segato P, Ninfo V. Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status. Histopathology. 2006; 49:274-282.
19. Blacque OE, Worrall DM. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem. 2002; 277:10783-10788.
20. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ. maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 1998; 58:5681-5685.
21. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet. 2002; 31:175-179.
22. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M. Nuclear cytokineactivated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature. 2007; 446:690-694.
23. Huang WC, Chen WS, Chen YJ, Wang LY, Hsu SC, Chen CC, Hung MC. Hepatitis B virus X protein induces IKKalpha nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells. J Cell Physiol. 2012; 227:1446-1454.
24. Xu J, Liu H, Chen L, Wang S, Zhou L, Yun X, Sun L, Wen Y, Gu j. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology. 2012; 143:199-212. e194.
25. Liu Y, Lou G, Wu W, Zheng M, Shi Y, Zhao D, Chen Z. Involvement of the NF-kappaB pathway in multidrug resistance induced by HBx in a hepatoma cell line. J Viral Hepat. 2011; 18:e439-446.
26. Zhang CZ, Zhang HT, Chen GG, Lai PB. Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment. Apoptosis. 2011; 16:683-695.
27. Maass N, Biallek M, Rosel F, Schem C, Ohike N, Zhang M, Jonat W, Nagasaki K. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun. 2002; 297:125-128.
28. Chen YJ, Chien PH, Chen WS, Chien YF, Hsu YY, Wang LY, Chen JY, Lin CW, Huang TC, Yu YL, Huang WC. Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells. Evid Based Complement Alternat Med. 2013; 2013:682380.
29. Cenik ES, Zamore PD. Argonaute proteins. Curr Biol. 2011; 21:R446-449.
30. Bodenstine TM, Seftor RE, Khalkhali-Ellis Z, Seftor EA, Pemberton PA, Hendrix MJ. Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 2012; 31:529-551.
31. Yu LR, Zeng R, Shao XX, Wang N, Xu YH, Xia QC. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis. 2000; 21:3058-3068.
32. Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol. 2011; 32:23-32.
33. Triulzi T, Ratti M, Tortoreto M, Ghirelli C, Aiello P, Regondi V, Di Modica M, Cominetti D, Carcangiu ML, Moliterni A, Balsari A, Casalini P, et al. Maspin influences response to doxorubicin by changing the tumor microenvironment organization. Int J Cancer. 2014; 134:2789-2797.
34. Biliran H, Sheng SJ. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 2001; 61:8676-8682.
35. Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res. 2004; 10:4140-4149.
36. Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK, Lee MO. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. 2008; 27:3405-3413.
37. Li X, Yin S, Meng Y, Sakr W, Sheng S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res. 2006; 66:9323-9329.
38. Lee SJ, Jang H, Park C. Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells. Int J Mol Med. 2012; 29:225-230.
39. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell. 2000; 5:905-915.
40. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, Akimoto C, Yamamoto Y, et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol. 2007; 9:604-611.
41. Yen C. HW MicroRNA expressions in human hepatocarcinoma cells in response to HBV X protein expression. GEO(2014) GSE56424 http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE56424.